StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) KPIs and segments

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.33+0.10 (+1.38%)

Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive Immunic's business

Coming soon

This tab will track the numbers specific to Immunic's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?